Homecision

cision

Thousands Across the U.S. To Go Bald and Take Action for Childhood Cancer Research This Month

Thousands Across the U.S. To Go Bald and Take Action for Childhood Cancer Research This Month

March 2, 2025

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – March 1, 2025

Travel & Hospitality

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – March 1, 2025

March 2, 2025

TransPerfect Acquires Technicolor Games

TransPerfect Acquires Technicolor Games

March 2, 2025

/R E P E A T — MEDIA ADVISORY – PS Serré to Participate in PDAC 2025/

/R E P E A T — MEDIA ADVISORY – PS Serré to Participate in PDAC 2025/

March 2, 2025

Canopy Growth Establishes New US$200 Million At-The-Market Program

Canopy Growth Establishes New US$200 Million At-The-Market Program

March 2, 2025

Master Traders Wanted: Bybit Launches Half-Million USDT Crypto Challenge

Master Traders Wanted: Bybit Launches Half-Million USDT Crypto Challenge

March 2, 2025

Hyundai Motor America Reports Record-Breaking February 2025 Sales

Hyundai Motor America Reports Record-Breaking February 2025 Sales

March 2, 2025

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

March 2, 2025

Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency)

Food & Beverage

Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency)

March 2, 2025

BIGLARI HOLDINGS INC. NEWS RELEASE

BIGLARI HOLDINGS INC. NEWS RELEASE

March 2, 2025

« 1 … 20 21 22 23 24 … 83 »